Factors associated with inappropriate reduced doses of non-vita-min K antagonist oral anticoagulants in patients with atrial fibrillation [PDF]
, 2021 The objective was to study the factors associated with inappropriate reduced doses of non-vitamin K antagonist oral anticoagulants (NOACs) in patients with non-valvular atrial fibrillation (AF) in real outpatient practice.Methods and materials.
E. I. Baranova +3 more
core +1 more source
COMPARATIVE EFFICACY AND SAFETY OF NEW ORAL ANTICOAGULANTS
Рациональная фармакотерапия в кардиологии, 2015 Indirect comparisons of new oral anticoagulants are performed with focus on their safety. Apixaban, an oral inhibitor of Xa factor, nowadays can be considered as a drug with very good safety profile according to randomized trials results and performed ...
V. A. Sulimov +2 more
doaj +1 more source
Left Ventricular Thrombosis: Current Perspective and Use of Direct Oral Anticoagulants [PDF]
, 2023 Left ventricular thrombus (LVT) is a serious risk factor for systemic embolism development. Despite the evident danger of this condition, current guidelines describe management of patients with this potentially fatal complication very briefly.
A. A. Sokolova +2 more
core +2 more sources
Носовое кровотечение в общеврачебной практике [PDF]
, 2016 УЧЕБНО-МЕТОДИЧЕСКИЕ ПОСОБИЯНОСОВОЕ КРОВОТЕЧЕНИЕГЕМОРРАГИИГЕМОСТАТИЧЕСКИЕ СРЕДСТВАСОСУДИСТЫЕ ГЕМОСТАТИЧЕСКИЕ РАССТРОЙСТВАВИЛЛЕБРАНДА БОЛЕЗНЬГЕМОРРАГИЧЕСКИЕ РАССТРОЙСТВАГЕМАТОЛОГИЧЕСКИЕ БОЛЕЗНИТРОМБОЦИТОПЕНИЯВ пособии освещены вопросы этиологии, патогенеза,
Журова, О. Н. +2 more
core
Plasma levels of direct Xa inhibitors apixaban and rivaroxaban in patients with venous thromboembolism in clinical practice [PDF]
Direct oral anticoagulants (DOACs) are used as a more effective and safe alternative to vitamin K antagonists, with a simpler dosing strategy and a stable pharmacokinetic profile.
D. Lukanova +4 more
core +1 more source
The problem of choosing an anticoagulant for stroke prevention in patients with atrial fibrillation
Медицинский совет, 2014 The article is a literature review on the problem of thromboembolic complications in non-valvular atrial fibrillation, the peculiarities of anticoagulant therapy and challenges associated with the selection of drugs for stroke prevention.
EL Dolgova, IM Sokolov, YG Schwarz
doaj +1 more source
Gastrointestinal Bleeding: a Cardiologist's Point of View [PDF]
, 2021 Oral anticoagulant therapy is widely used in different patients for the prevention and treatment of thromboembolic events: in atrial fibrillation, deep vein thrombosis/pulmonary embolism, acute coronary syndrome, in the early postoperative period after ...
L. N. Mishchenko, O. V. Averkov
core +2 more sources
The main causes and current principles of prevention of cardioembolic stroke
Медицинский совет, 2015 Cardiocerebral embolism is responsible for the development of 30-40% of ischemic stroke events. [1-3] Apart from its high incidence, cardioembolic stroke (CEI) is often associated with significant residual impairment of motor, speech and coordination ...
A. V. Fonyakin, L. A. Geraskina
doaj +1 more source
Effectiveness and safety of direct oral anticoagulants in patients with atrial fibrillation and chronic kidney disease: a systematic review and meta-analysis of clinical trials [PDF]
Aim. To analyze published clinical trials to evaluate the safety and effectiveness of direct oral anticoagulants in comparison with warfarin in a population of patients with atrial fibrillation and chronic kidney disease stages C4-C5.Material and methods.
E. M. Mezhonov +3 more
core +2 more sources
Медицинский совет, 2016 Применение пероральных антикоагулянтов у пациентов в пожилом возрасте представляет серьезную проблему для клиницистов. У лиц с фибрилляцией предсердий (ФП) возраст старше 70 лет является фактором, существенно повышающим риск тромбоэмболических событий, и
doaj +1 more source